ACADIA Pharmaceuticals Inc. (ACAD): Price and Financial Metrics

ACADIA Pharmaceuticals Inc. (ACAD): $16.72

0.27 (-1.59%)

POWR Rating

Component Grades








Add ACAD to Watchlist
Sign Up

ACAD Price/Volume Stats

Current price $16.72 52-week high $33.99
Prev. close $16.99 52-week low $16.60
Day low $16.64 Volume 561,476
Day high $17.24 Avg. volume 1,760,954
50-day MA $20.64 Dividend yield N/A
200-day MA $24.64 Market Cap 2.75B

ACAD Stock Price Chart Interactive Chart >

ACADIA Pharmaceuticals Inc. (ACAD) Company Bio

Acadia Pharmaceuticals Inc is a biotechnology company which develops and commercializes biopharmaceutical products to address central nervous system disorders. The firm aims to discover small molecule drugs to address Parkinson's, Alzheimer's and schizophrenia. The company was founded in 1993 by Mark Brann, PhD., a professor at the University of Vermont, under the name Receptor Technologies. By 1997, the company established its headquarters in San Diego, California and changed its name to Acadia Pharmaceuticals Inc and currently employs over 400 people. Since 2015, Stephen R. Davis serves as Acadia’s Chief Executive Officer and member of the board of directors. Competition for Acadia includes Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, and off-label branded and generic antipsychotics.

ACAD Latest News Stream

Event/Time News Detail
Loading, please wait...

ACAD Latest Social Stream

Loading social stream, please wait...

View Full ACAD Social Stream

Latest ACAD News From Around the Web

Below are the latest news stories about ACADIA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate ACAD as an investment opportunity.

Acadia Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 9, 2024

SAN DIEGO, December 21, 2023--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesday, January 9, 2024, at 9:00 a.m. Pacific Time, followed by a question and answer session.

Yahoo | December 21, 2023

Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, December 18, 2023--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that on December 13, 2023, the Compensation Committee of Acadia’s Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 33,647 shares of common stock and 20,146 restricted stock units ("RSUs") to eight new employees under Acadia’s 2023 Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’

Yahoo | December 18, 2023

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Shares Fly 25% But Investors Aren't Buying For Growth

ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD ) shareholders would be excited to see that the share price has had a great...

Yahoo | December 18, 2023

Delaware District Court Rules in Favor of Acadia on Formulation Patent Construction (Markman) Claims Regarding NUPLAZID® (pimavanserin)

SAN DIEGO, December 14, 2023--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the U.S. District Court for the District of Delaware has issued a Claim Construction Order in favor of Acadia regarding its ‘721 formulation patent for NUPLAZID® (pimavanserin), Acadia’s drug for the treatment of Parkinson’s Disease Psychosis. In today’s Order, the Court ruled in favor of Acadia on all of the disputed claim construction points.

Yahoo | December 14, 2023

Acadia Soars To A Four-Month High After Winning A Patent Battle For Its Biggest Drug

Acadia notched a win in a patent battle Wednesday pertaining to its Parkinson's drug and ACAD stock soared to a four-month high.

Yahoo | December 13, 2023

Read More 'ACAD' Stories Here

ACAD Price Returns

1-mo -6.85%
3-mo -38.51%
6-mo -25.69%
1-year -16.98%
3-year -18.44%
5-year -31.62%
YTD -46.60%
2023 96.67%
2022 -31.79%
2021 -56.34%
2020 24.96%
2019 164.56%

Continue Researching ACAD

Here are a few links from around the web to help you further your research on Acadia Pharmaceuticals Inc's stock as an investment opportunity:

Acadia Pharmaceuticals Inc (ACAD) Stock Price | Nasdaq
Acadia Pharmaceuticals Inc (ACAD) Stock Quote, History and News - Yahoo Finance
Acadia Pharmaceuticals Inc (ACAD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!